Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research  How it helps Latest publication
Ad26.COV2.S
Emergency use authorization Experimental Vaccine Jun/22/2022
gp96-Ig-S
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/26/2021
S-8510
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
(2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
mAb 58
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
PF-00835231
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
rLVS ΔcapB/SCoV2 MN
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/30/2021
COV2-2489
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/16/2021
Nb11‐59
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/04/2021
COV2-2676
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/16/2021
12f
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021
SinaCurcumin®
Potential treatment - clinical evidence Experimental Antiviral Mar/28/2021
ZF2001
Potential treatment - clinical evidence Experimental Vaccine Mar/24/2021
Nirmatrelvir
Emergency use authorization Experimental Antiviral Jun/23/2022
BBIBP-CorV
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2021
mAb 4A8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
(Recombinant) IL-3
Potential treatment - pre-clinical evidence Experimental Other treatment Feb/18/2021
[SARSHRC-PEG4]2-chol
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/17/2021
MI-09
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021